| TET2 deficiency causes germinal center hyperplasia, impairs plasma cell differentiation, and promotes B-cell lymphomagenesis PM Dominguez, H Ghamlouch, W Rosikiewicz, P Kumar, W Béguelin, ... Cancer discovery 8 (12), 1632-1653, 2018 | 151 | 2018 |
| A Combination of Cytokines Rescues Highly Purified Leukemic CLL B-Cells from Spontaneous Apoptosis In Vitro H Ghamlouch, H Ouled-Haddou, G Damaj, B Royer, B Gubler, ... PloS one 8 (3), e60370, 2013 | 59 | 2013 |
| Chronic lymphocytic leukemia B-cell normal cellular counterpart: clues from a functional perspective W Darwiche, B Gubler, JP Marolleau, H Ghamlouch Frontiers in immunology 9, 683, 2018 | 58 | 2018 |
| B-cell tumor development in Tet2-deficient mice E Mouly, H Ghamlouch, V Della-Valle, L Scourzic, C Quivoron, ... Blood advances 2 (6), 703-714, 2018 | 53 | 2018 |
| A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset D Selimoglu-Buet, J Rivière, H Ghamlouch, L Bencheikh, C Lacout, ... Nature communications 9 (1), 5455, 2018 | 50 | 2018 |
| Impact of chronic exposure to the pesticide chlorpyrifos on respiratory parameters and sleep apnea in juvenile and adult rats W Darwiche, J Gay-Quéheillard, S Delanaud, H El Khayat El Sabbouri, ... PloS one 13 (1), e0191237, 2018 | 39 | 2018 |
| TET2 deficiency reprograms the germinal center B cell epigenome and silences genes linked to lymphomagenesis W Rosikiewicz, X Chen, PM Dominguez, H Ghamlouch, S Aoufouchi, ... Science advances 6 (25), eaay5872, 2020 | 38 | 2020 |
| A recurrent activating missense mutation in Waldenström macroglobulinemia affects the DNA binding of the ETS transcription factor SPI1 and enhances proliferation D Roos-Weil, C Decaudin, M Armand, V Della-Valle, MK Diop, ... Cancer Discovery 9 (6), 796-811, 2019 | 30 | 2019 |
| Chromothripsis as a pathogenic driver of multiple myeloma F Maura, EM Boyle, EH Rustad, C Ashby, D Kaminetzky, B Bruno, ... Seminars in cell & developmental biology 123, 115-123, 2022 | 25 | 2022 |
| Chronic lymphocytic leukaemia genomics and the precision medicine era H Ghamlouch, F Nguyen‐Khac, OA Bernard British journal of haematology 178 (6), 852-870, 2017 | 25 | 2017 |
| TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20+ Antibody-Secreting Cells H Ghamlouch, H Ouled-Haddou, A Guyart, A Regnier, S Trudel, ... Frontiers in immunology 5, 292, 2014 | 22 | 2014 |
| Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice V Della-Valle, D Roos-Weil, L Scourzic, E Mouly, Z Aid, W Darwiche, ... Blood cancer journal 10 (3), 38, 2020 | 19 | 2020 |
| Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia W Darwiche, C Gomila, H Ouled-Haddou, M Naudot, C Doualle, P Morel, ... Journal of experimental & clinical cancer research 39, 1-17, 2020 | 18 | 2020 |
| Identification of 2 DNA methylation subtypes of Waldenström macroglobulinemia with plasma and memory B-cell features D Roos-Weil, B Giacopelli, M Armand, V Della-Valle, H Ghamlouch, ... Blood, The Journal of the American Society of Hematology 136 (5), 585-595, 2020 | 18 | 2020 |
| Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression I Marcq, R Nyga, F Cartier, RS Amrathlal, C Ossart, H Ouled-Haddou, ... PLoS One 8 (12), e82918, 2013 | 18 | 2013 |
| Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab‐secreting cells H Ghamlouch, H Ouled‐Haddou, A Guyart, A Regnier, S Trudel, ... Immunology and cell biology 92 (7), 591-604, 2014 | 16 | 2014 |
| Impact of prenatal and postnatal exposure to the pesticide chlorpyrifos on the contraction of rat ileal muscle strips: involvement of an inducible nitric oxide synthase … W Darwiche, S Delanaud, S Dupont, H Ghamlouch, W Ramadan, ... Neurogastroenterology & Motility 29 (2), e12918, 2017 | 15 | 2017 |
| Gain of the short arm of chromosome 2 (2p gain) has a significant role in drug‐resistant chronic lymphocytic leukemia F Kostopoulou, C Gabillaud, E Chapiro, B Grange, J Tran, S Bouzy, ... Cancer Medicine 8 (6), 3131-3141, 2019 | 13 | 2019 |
| Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens F Maura, EM Boyle, D Coffey, K Maclachlan, D Gagler, B Diamond, ... Nature cancer 4 (12), 1660-1674, 2023 | 12 | 2023 |
| Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells H Ghamlouch, W Darwiche, A Hodroge, H Ouled-Haddou, S Dupont, ... Oncotarget 6 (21), 18484, 2015 | 11 | 2015 |
